Register entry
WuXi Biologics Co., Ltd.
- Registered sites
- 18
- Drug products
- 10
- Live patents
- 0
- Countries
- 4
- Base
- China
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
18| Site | Location | Operations | FEI |
|---|---|---|---|
| WuXi Biologics (Hangzhou FTZ) Co., Ltd. | HangzhouChina | Analytical testing, Active ingredient (API) manufacture | 3042736734 |
| WuXi Biologics (Hangzhou) Co., Ltd. | HangzhouChina | Analytical testing, Active ingredient (API) manufacture | 3040977029 |
| WuXi Biologics (Zhejiang) Co., Ltd. | HangzhouChina | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3023443270 |
| WuXi Biologics (Shanghai FX) Co., Ltd. | ShanghaiChina | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3030269812 |
| WuXi Biologics (Shanghai) Co., Ltd. | ShanghaiChina | Analytical testing, Active ingredient (API) manufacture | 3012317728 |
| WuXi Biologics Biosafety Testing (Shanghai) Co., Ltd. | ShanghaiChina | Analytical testing | 3034423545 |
| WuXi Biologics (Hebei) Co., Ltd. | ShijiazhuangChina | Analytical testing, Active ingredient (API) manufacture | 3032341421 |
| Suzhou Vaccines Co., Ltd. | SuzhouChina | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3030379046 |
| Suzhou Vaccines Co., Ltd. DP17 Site | SuzhouChina | Analytical testing, Finished drug manufacture | 3030585419 |
| WuXi Biologics (Suzhou) Co., Ltd. | SuzhouChina | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3038731911 |
| WuXi Biologics Biosafety Testing (Suzhou) Co., Ltd. | SuzhouChina | Analytical testing | 3015655844 |
| WuXi Biologics Co., Ltd. | WuxiChina | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3010606982 |
| WuXi XDC Co., Ltd. | WuxiChina | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3020119387 |
| WuXi Biologics Germany GmbH | WuppertalGermany | Analytical testing | 3032710919 |
| WuXi Biologics Ireland Limited | DundalkIreland | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3026506583 |
| WuXi Biologics USA, LLC | Cranbury, NJUnited States | Analytical testing, Active ingredient (API) manufacture | 3039674215 |
| Wuxi Biologics USA, LLC | Cranbury, NJUnited States | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3017966592 |
| Wuxi Biologics USA, LLC | Robbinsville, NJUnited States | Analytical testing, Finished drug manufacture | 3030266883 |
Catalogue
Marketed products
10Showing 10 of 10.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Berahyaluronidase alfa | LIQUID | BULK INGREDIENT |
| - | Cipaglucosidase alfa | POWDER, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Dostarlimab | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Ibalizumab | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | aflibercept-jbvf | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | cipaglucosidase alfa-atga | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | denosumab-bnht | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | pemivibart | INJECTION | DRUG FOR FURTHER PROCESSING |
| - | vilobelimab | INJECTION, SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | zanidatamab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.